Years Before Diagnosis: How Autoantibodies Signal Emerging Type 1 Diabetes in Adults

Type 1 diabetes is often thought of as a childhood disease, but research shows that adult-onset Type 1 diabetes (AOT1D) is actually more common than the childhood form. Despite this, it frequently goes unrecognized—doctors and patients may assume adult diabetes is Type 2. A new study published in medRxiv examined medical records and blood samples from 169 adults with Type 1 diabetes and 40 healthy controls from the U.S. Military Health System to understand how autoimmunity develops in adults before diagnosis occurs.

The study found that 85% of adults with Type 1 diabetes had at least one detectable islet autoantibody before they received their diagnosis. This means that for most people, the body's immune system was already attacking the insulin-producing cells in the pancreas, sometimes long before symptoms appeared or blood sugar levels rose enough to trigger a diagnosis.

The researchers tracked when autoantibodies first became detectable by looking at the earliest available blood samples for each person. The pattern was clear: as the time to diagnosis got closer, more people tested positive for autoantibodies. More than 20 years before diagnosis, 38% were seropositive. This increased to 44% at 20-15 years before diagnosis, then climbed to 59% at 15-10 years, 73% at 10-5 years, and 91% within the final 5 years before diagnosis.

The study identified five different autoantibodies associated with Type 1 diabetes: IA-2, GADA, IA-2β, ZnT8-R, and ZnT8-W. Among the prediagnostic blood samples, IA-2 was most prevalent (50%), followed closely by GADA (46%). The others appeared less frequently: IA-2β in 34%, ZnT8-R in 27%, and ZnT8-W in 15%.

Interestingly, having multiple autoantibodies was more common than having just one. Among the 144 people who tested positive for autoantibodies, half (50%) had two or more. When only one autoantibody was present, GADA and IA-2/IA-2β were roughly equally common (22% and 24%, respectively), while isolated ZnT8 positivity was rare (4%).

Timing matters too. When researchers looked at which autoantibody appeared first, GADA stood out. It had a median onset of approximately 7.9 years before diagnosis, suggesting it may be an earliest marker of developing autoimmunity in adults.

This research adds to our understanding of how Type 1 diabetes develops in adults and highlights the potential value of autoantibody screening. Because autoantibodies can appear years before diagnosis, identifying them earlier could theoretically allow for earlier intervention or monitoring—though this would require further research to confirm benefit.

For now, the findings underscore an important point: adult-onset Type 1 diabetes does not appear suddenly. It develops gradually as the immune system becomes increasingly activated against the pancreas. Better awareness of this process among patients and healthcare providers could reduce the delay between symptom onset and accurate diagnosis.

Source: medRxiv : the preprint server for health sciences. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.